| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |